Dr. Marcel Binz from the Institute for Human-Centered AI at Helmholtz Munich has received a Starting Grant from the European Research Council (ERC). Through the MIDAS project, he will develop large-scale computational models designed to simulate,…
AI-Designed Proteins Enable a New Generation of RNA Transporters
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Synthetic Transfer Vehicles (STVs), an entirely new class of RNA transporters. To do so, they combined naturally occurring protein building blocks with…
Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body
Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich (TUM), have identified a previously unknown mechanism that can drive…
Public Engagement,
Molecular Targets and Therapeutics,
MCD,
Marcus Conrad Receives Inaugural Raghav Prize for Rare Disease Research
The CureGPX4 Foundation has named Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, as the first recipient of the Raghav Prize for Rare Disease and Citizen Science. The prize recognizes his research into…
